Regeneron CEO says the next big thing for biotech isn't AI, it's gene therapy

Regeneron CEO Leonard Schleifer detailed the biotech company's newest ventures in the pharmaceutical industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.